Close
Nordic 9Nordic 9

Aphelion Capital (investor - Venture Capital)

United States aphelioncapital.net
See something wrong or missing? Let us know
Offices:San Francisco

Aphelion Capital is a healthcare venture capital firm from USA

Average round investment:42M USD
Average number per year:1.0
Distribution: 2024 (1)
Portfolio companies: United Kingdom Phagenesis
Mostly invests in: United Kingdom United Kingdom (1) Health services (1)

1 tracked investments in:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Investors with similar profile to Aphelion Capital

Name Criteria
Hong Kong CR-CP Life Science Fund
73%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
United States Vivo Capital
73%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Germany Evotec AG
73%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Japan Kyoritsu Holdings
73%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
United States Digitalis Ventures
73%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
United States Magnetic Ventures
73%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
United States Mark P. Stevenson
73%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Germany Atai Life Sciences
73%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Canada Sectoral Asset Management
73%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
United Kingdom Dementia Discovery Fund
73%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.2
  • Active last 12 months: Yes
Top